加载中
NASDAQHealthcareMedical - Devices
最新数据
US$1.3649
−US$0.1651 · -10.79%
Quantum-Si incorporated operates within the life sciences sector, focusing on the creation of an advanced platform for individual molecule detection. This innovative technology is designed to streamline sample preparation and subsequent sequencing processes. The company offers a unique, proprietary single molecule detection system that draws on advancements from the semiconductor industry. This system is specifically applied to the field of proteomics, paving the way for next-generation protein sequencing. Established in 2013, Quantum-Si's headquarters are located in Guilford, Connecticut.
常规交易时段
US$1.3649
−US$0.1651 · -10.79%
盘中时间采用ET。市场数据可能有所延迟。
Quantum-Si incorporated operates within the life sciences sector, focusing on the creation of an advanced platform for individual molecule detection. This innovative technology is designed to streamline sample preparation and subsequent sequencing processes. The company offers a unique, proprietary single molecule detection system that draws on advancements from the semiconductor industry. This system is specifically applied to the field of proteomics, paving the way for next-generation protein sequencing. Established in 2013, Quantum-Si's headquarters are located in Guilford, Connecticut.
日内区间
当前US$1.3649
52周区间
当前US$1.3649
盘中时间采用ET。市场数据可能有所延迟。
GoAI 评分
强力卖出
估值
18
估值过高
情绪
33
看跌
风险
88
极高风险
动量
21
动能减弱
完整 GoAI 研究
继续查看更深入的依据、催化因素和风险。
Quantum-Si incorporated operates within the life sciences sector, focusing on the creation of an advanced platform for individual molecule detection. This innovative technology is designed to streamline sample preparation and subsequent sequencing processes. The company offers a unique, proprietary single molecule detection system that draws on advancements from the semiconductor industry. This system is specifically applied to the field of proteomics, paving the way for next-generation protein sequencing. Established in 2013, Quantum-Si's headquarters are located in Guilford, Connecticut.
日内区间
当前US$1.3649
52周区间
当前US$1.3649
盈利能力占已公布营收的百分比。
营收
营业利润
净利润
| 项目（USD） | 2025财年 | 2024财年 | 2023财年 | 2022财年 | 2021财年 |
|---|---|---|---|---|---|
| 营收 | 243.6万 USD | 305.8万 USD | 108.2万 USD | — | — |
| 销货成本 | 128.3万 USD | 145.8万 USD | 59.4万 USD | — | — |
| 毛利 | 115.3万 USD | 160万 USD | 48.8万 USD | — | — |
| 研究与开发 | 5375.9万 USD | 5964.1万 USD | 6702.5万 USD | 7206.2万 USD | 4657.5万 USD |
| 销售、一般及管理费用 | 4475.4万 USD | 5053.5万 USD | 4463.4万 USD | 4229.6万 USD | 5033.3万 USD |
| 营业费用 | 9851.3万 USD | 1.1亿 USD | 1.12亿 USD | 1.24亿 USD | 9690.8万 USD |
| 利息收入 | 896.4万 USD | — | — | — | — |
| 利息支出 | — | — | — | — | 5000 USD |
| 折旧和摊销 | 445.4万 USD | 460万 USD | 415.6万 USD | 258.4万 USD | 104.1万 USD |
| 营业利润 | −9736万 USD | −1.09亿 USD | −1.11亿 USD | −1.24亿 USD | −9690.8万 USD |
| 净利润 | −1.01亿 USD | −1.01亿 USD | −9596万 USD | −1.32亿 USD | −9498.9万 USD |
公司数据更新于 2026年10月12日。
近期已公布业绩
近期已公布业绩
报告持有此股票敞口的交易所交易基金。
ARK Genomic Revolution ETFARKG848.32万0.41%15.57亿 USD0.75%US$48.73-5.01%
Vanguard Morningstar Total Stock Market ETFVTI410.06万0.00%2.3万亿 USD0.03%US$381.49-0.12%
iShares Biotechnology ETFIBB201.49万0.02%108.2亿 USD0.44%US$204.28-1.07%
Vanguard Extended Market ETFVXF158.74万0.00%954亿 USD0.05%US$233.9-0.47%
Invesco RAFI US 1500 Small-Mid ETFPRFZ70.64万0.03%26.7亿 USD0.36%US$52.985-0.33%
iShares Core S&P Total U.S. Stock Market ETFITOT66.61万0.00%980.88亿 USD0.03%US$169.42-0.14%
Vanguard Health Care ETFVHT38.54万0.00%220亿 USD0.09%US$319.51+0.16%
EA Series Trust - EA Bridgeway Ultra-Small Company Market ETFBUSM30万0.26%1.17亿 USD0.73%US$15.85-0.57%ARK Genomic Revolution ETFARKGVanguard Morningstar Total Stock Market ETFVTIiShares Biotechnology ETFIBBVanguard Extended Market ETFVXFInvesco RAFI US 1500 Small-Mid ETFPRFZiShares Core S&P Total U.S. Stock Market ETFITOTVanguard Health Care ETFVHTEA Series Trust - EA Bridgeway Ultra-Small Company Market ETFBUSMAI 生成内容及延迟市场数据仅供信息与教育用途，不构成投资建议。
